Clinical Trial Update: A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia [Phase 1, Phase 2]

View source ↗

Summary

A pilot study evaluating fludarabine plus cyclophosphamide in refractory severe aplastic anemia completed phases 1 and 2 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Neutropenia
• Pancytopenia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Aplastic Anemia, Neutropenia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-03-02